Accelerating Access to Critical Therapies for Als Reauthorization Act of 2026
The House debated H.R. 8205, which reauthorizes through fiscal year 2031 the Accelerating Access to Critical Therapies for ALS Act, funding NIH and FDA programs for ALS research, expanded access to investigational treatments, and a public-private partnership for neurodegenerative disease therapies. Members from both parties spoke in support: Guthrie and Calvert said the programs help fund research and treatments for ALS, and DeGette noted the disease affects about 5,000 Americans each year. Quigley described his constituent Brian Wallach, diagnosed with ALS, and Guthrie recalled constituents from his district affected by the disease. The debate was brief and bipartisan, focused on passing the reauthorization.Written by AI from the debate. Updated .
No matching statements
No statements match this filter
Choose another party or return to all statements.
More from issue 118
- House of Representatives Honoring Life of Douglas Graham 4 statements
- House of Representatives Recognizing Larry "the Grinch" Stone 2 statements
- House of Representatives Commemorating 82nd Anniversary of Liberation of Guam 2 statements
- House of Representatives Choices for Increased Mobility Act of 2026 5 statements
- House of Representatives Destruction of Hazardous Imports Act 6 statements
- House of Representatives FDA Modernization Act 3.0 6 statements
- House of Representatives Reauthorizing the Kay Hagan Tick Act 6 statements
- House of Representatives Stem Cell Therapeutic and Research Reauthorization Act of 2025 6 statements
- House of Representatives Accelerating Access to Dementia and Alzheimer's Provider Training Act 6 statements
- House of Representatives Action for Dental Health Act 7 statements
- House of Representatives Programs to Prevent, Detect, and Treat Traumatic Brain Injuries 4 statements
- House of Representatives Early Act Reauthorization of 2025 7 statements
- House of Representatives Deondra Dixon Include Project Act of 2025 5 statements
- House of Representatives NIH Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone Act 7 statements
- House of Representatives Accelerating Access to Critical Therapies for Als Reauthorization Act of 2026 6 statements
- House of Representatives Putting Patients First by Strengthening Provider Accountability in Feca Act 6 statements
- House of Representatives Value over Cost Act of 2026 3 statements
- House of Representatives Ensuring Federal Purchasing Efficiency Act 6 statements
- House of Representatives Stop Secret Spending Act of 2025 6 statements
- House of Representatives Federal Improvement in Technology Procurement Act 4 statements
- House of Representatives Federal Relocation Payment Improvement Act 5 statements
- House of Representatives Billion Dollar Boondoggle Act 5 statements
- House of Representatives Expanding Whistleblower Protections for Contractors Act of 2026 3 statements
- House of Representatives Nucleic Acid Standards for Biosecurity Act 5 statements
- House of Representatives Next-Generation Geothermal Research and Development Act 7 statements
- House of Representatives Recognizing 100th Anniversary of Long Island Association 9 statements
- House of Representatives Honoring the Life and Legacy of Congressman John Lewis 4 statements
- Senate Cloture Motion (Executive Calendar) 2 statements
- Senate Order for Adjournment 17 statements